Status | Study |
Completed |
Study Name: Intra-articular Betamethasone and the Hypothalamic-pituitary-adrenal Axis Condition: Adrenal Suppression Date: 2013-02-21 |
Completed |
Study Name: Pharmacokinetics of 122-0551 and Its Effects on Adrenal Suppression Condition: Plaque Psoriasis Date: 2012-09-27 Interventions: Drug: 122-0551 Applied twice daily for 2 weeks |
Completed |
Study Name: Hydrocortisone Replacement in Patients With Secondary Adrenal Insufficiency (SUPREME CORT) Condition: Adrenal Insufficiency Date: 2012-02-07 Interventions: Drug: Hydrocortisone Patients receive either a low dose HC (0.2-0.3 mg/kg body weight) for 10 weeks foll |
Not yet recruiting |
Study Name: Effect of Longer-term Adrenal Suppression Using Low Dose Hydrocortisone on Androgen Overproduction Condition: Hyperandrogenemia Obesity Polycystic Ovary Syndrome Date: 2011-08-22 Interventions: Drug: Hydrocortisone 10mg/m2/p |
Not yet recruiting |
Study Name: Effect of Short Term Adrenal Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess Condition: Hyperandrogenemia Obesity Polycystic Ovary Syndrome Date: 2011-08-19 Interventions: Drug: Hydrocortisone 10 mg/m2/per day PO at bedtime (X4 weeks) |
Completed |
Study Name: Safety Study Evaluating the Adrenal Suppression Potential of Product 0405 in Pediatric Subjects With Atopic Dermatitis Condition: Atopic Dermatitis Date: 2010-10-28 Interventions: Drug: Product 0405 Product 0405 will be administered topically, twice daily for 28 days. |
Completed |
Study Name: Prevalence Study of Adrenal Suppression After Corticosteroids During Chemotherapy Condition: Adrenal Suppression Date: 2010-09-23 Interventions: Other: Chemotherapy This study is designed only to look at the prevalence of adrenal suppression during |
Completed |
Study Name: Dehydroepiandrosterone Substitution in Adolescent and Young Women With Central Adrenal Insufficiency Condition: Adrenal Insufficiency Date: 2007-12-14 Interventions: Drug: Dehydroepiandrosterone 2 |
Completed |
Study Name: Adrenal Suppression and Adrenal Recovery Induced by Megestrol Acetate Condition: Adrenal Insufficiency Date: 2007-12-13 Interventions: Drug: megestrol acetate 600 mg by mouth daily |
Completed |
Study Name: Does Intravitreal Injection of Triamcinolone Acetonide Impairs the Adrenal Function Condition: Secondary Adrenal Insufficiency Date: 2007-11-18 |